Analysis of the Contribution to Type 2 Diabetes Susceptibility of Sequence Variation in the Gene Encoding Stearoyl-CoA Desaturase, a Key Regulator of Lipid and Carbohydrate Metabolism
Overview
Authors
Affiliations
Aims/hypothesis: Stearoyl-CoA desaturase (SCD) is emerging as a key regulator of lipid and carbohydrate metabolism. Scd-null mice display a beneficial metabolic phenotype characterised by resistance to obesity, diabetes and hyperlipidaemia. The human homologue, SCD, maps to a region of chromosome 10 linked to type 2 diabetes, and SCD activity correlates with insulin sensitivity. Given this strong positional and biological candidacy, the present study sought to establish whether sequence variation in SCD influences susceptibility to type 2 diabetes and related traits.
Methods: The SCD gene was resequenced in 23 diabetic subjects. Six variants within coding and adjacent sequence, including a non-synonymous SNP in exon 5 (M224L), were selected for genotyping in a primary set of 608 diabetic subjects and 600 control subjects.
Results: There was no association (at the allele, genotype or haplotype level) with type 2 diabetes, although genotype frequencies at the +14301 A>C SNP in the 3' untranslated region showed borderline association (p~0.06) when evidence for linkage was taken into account. However, replication studies (350 young-onset diabetic patients; 747 controls) failed to confirm any relationship with diabetes for this variant. No significant associations were seen for diabetes-related traits including BMI and waist-to-hip ratio.
Conclusions/interpretation: The present study, the first reported analysis of this gene, indicates that the SCD variants typed do not explain chromosome-10-encoded susceptibility to type 2 diabetes. Although this study provided no evidence that SCD sequence variation influences diabetes susceptibility or related traits, SCD remains a major target for pharmaceutical and/or environmental manipulation.
Antidiabetic Effect of Radix Based on Regulation of TRPV1 and SCD1.
Liu Y, Zhu R, Liu B, Wang W, Yang P, Cao Z Front Pharmacol. 2022; 13:875014.
PMID: 35694255 PMC: 9178243. DOI: 10.3389/fphar.2022.875014.
Liu Z, Yin X, Mai H, Li G, Lin Z, Jie W Mol Genet Genomic Med. 2020; 8(3):e1136.
PMID: 31965762 PMC: 7057097. DOI: 10.1002/mgg3.1136.
Key genes and co-expression network analysis in the livers of type 2 diabetes patients.
Li L, Pan Z, Yang X J Diabetes Investig. 2018; 10(4):951-962.
PMID: 30592156 PMC: 6626963. DOI: 10.1111/jdi.12998.
Lemas D, Klimentidis Y, Aslibekyan S, Wiener H, OBrien D, Hopkins S Mol Nutr Food Res. 2016; 60(12):2642-2653.
PMID: 27467133 PMC: 5148654. DOI: 10.1002/mnfr.201600170.
Lu Y, Zhou Z, Tao J, Dou B, Gao M, Liu Y Lipids Health Dis. 2014; 13:53.
PMID: 24650127 PMC: 3974181. DOI: 10.1186/1476-511X-13-53.